Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 3
1947 1
1948 1
1949 1
1950 2
1951 4
1952 7
1953 7
1954 5
1955 2
1956 2
1957 4
1958 4
1959 1
1960 2
1961 3
1962 2
1963 9
1964 22
1965 29
1966 9
1967 16
1968 20
1969 27
1970 23
1971 29
1972 32
1973 32
1974 33
1975 38
1976 45
1977 43
1978 43
1979 44
1980 59
1981 45
1982 65
1983 51
1984 56
1985 74
1986 70
1987 70
1988 51
1989 89
1990 113
1991 109
1992 113
1993 138
1994 146
1995 147
1996 130
1997 164
1998 171
1999 165
2000 203
2001 214
2002 227
2003 265
2004 223
2005 258
2006 267
2007 289
2008 320
2009 335
2010 393
2011 377
2012 500
2013 536
2014 507
2015 510
2016 518
2017 557
2018 555
2019 584
2020 682
2021 787
2022 672
2023 658
2024 234

Text availability

Article attribute

Article type

Publication date

Search Results

11,786 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Vasculitis of systemic vasculature"
Page 1
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.
Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, Holle JU, Hollinger N, Karadag O, Kronbichler A, Little MA, Luqmani RA, Mahr A, Merkel PA, Mohammad AJ, Monti S, Mukhtyar CB, Musial J, Price-Kuehne F, Segelmark M, Teng YKO, Terrier B, Tomasson G, Vaglio A, Vassilopoulos D, Verhoeven P, Jayne D. Hellmich B, et al. Ann Rheum Dis. 2024 Jan 2;83(1):30-47. doi: 10.1136/ard-2022-223764. Ann Rheum Dis. 2024. PMID: 36927642
BACKGROUND: Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several randomised clinical trials have been published that have the potential to change clinical care and s …
BACKGROUND: Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated …
Systemic vasculitis: one year in review 2023.
Moretti M, Treppo E, Monti S, La Rocca G, Del Frate G, Delvino P, Italiano N, Di Cianni F, D'Alessandro F, Talarico R, Ferro F, Quartuccio L, Baldini C. Moretti M, et al. Clin Exp Rheumatol. 2023 Apr;41(4):765-773. doi: 10.55563/clinexprheumatol/zf4daj. Epub 2023 Apr 18. Clin Exp Rheumatol. 2023. PMID: 37073639 Free article. Review.
The recent COVID-19 pandemic has had a significant impact on the epidemiology and management of patients with systemic vasculitis. In parallel, new insights have been provided on systemic vasculitis pathogenetic mechanisms, possible new therapeutic tar …
The recent COVID-19 pandemic has had a significant impact on the epidemiology and management of patients with systemic vasculitis …
Eosinophilic granulomatosis with polyangiitis.
Romero Gómez C, Hernández Negrín H, Ayala Gutiérrez MDM. Romero Gómez C, et al. Med Clin (Barc). 2023 Apr 6;160(7):310-317. doi: 10.1016/j.medcli.2023.01.003. Epub 2023 Feb 9. Med Clin (Barc). 2023. PMID: 36774291 Review. English, Spanish.
Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis characterized by the presence of asthma associated with eosinophilia, eosinophilic infiltration of different organs, and vasculitis of small and medium-sized vessels. Although class …
Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis characterized by the presence of asthma associat …
Cutaneous Vasculitis: Review on Diagnosis and Clinicopathologic Correlations.
Frumholtz L, Laurent-Roussel S, Lipsker D, Terrier B. Frumholtz L, et al. Clin Rev Allergy Immunol. 2021 Oct;61(2):181-193. doi: 10.1007/s12016-020-08788-4. Clin Rev Allergy Immunol. 2021. PMID: 32378145 Review.
The skin is often involved. Also, cutaneous vasculitis can reflect a cutaneous component of a systemic vasculitis, a skin-limited or skin-dominant expression or variant of a systemic vasculitis, or be a single-organ vasculitis per se. ... …
The skin is often involved. Also, cutaneous vasculitis can reflect a cutaneous component of a systemic vasculitis, a sk …
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis.
Sebastiani M, Manfredi A, Vacchi C, Cassone G, Faverio P, Cavazza A, Sverzellati N, Salvarani C, Luppi F. Sebastiani M, et al. Clin Exp Rheumatol. 2020 Mar-Apr;38 Suppl 124(2):221-231. Epub 2020 Apr 22. Clin Exp Rheumatol. 2020. PMID: 32324122 Free article. Review.
Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) is a group of systemic vasculitides that predominantly affect small vessels, including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis wi …
Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) is a group of systemic vasculitides that predominantl …
Modification and validation of the Birmingham Vasculitis Activity Score (version 3).
Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, Flossmann O, Hall C, Hollywood J, Jayne D, Jones R, Lanyon P, Muir A, Scott D, Young L, Luqmani RA. Mukhtyar C, et al. Ann Rheum Dis. 2009 Dec;68(12):1827-32. doi: 10.1136/ard.2008.101279. Epub 2008 Dec 3. Ann Rheum Dis. 2009. PMID: 19054820
BACKGROUND: Comprehensive multisystem clinical assessment using the Birmingham Vasculitis Activity score (BVAS) is widely used in therapeutic studies of systemic vasculitis. ...The new version of BVAS is validated for assessment of systemic vasculit …
BACKGROUND: Comprehensive multisystem clinical assessment using the Birmingham Vasculitis Activity score (BVAS) is widely used in the …
Polyarteritis nodosa: an evolving primary systemic vasculitis.
Springer JM, Byram K. Springer JM, et al. Postgrad Med. 2023 Jan;135(sup1):61-68. doi: 10.1080/00325481.2022.2088940. Epub 2022 Jun 22. Postgrad Med. 2023. PMID: 35709399 Review.
Polyarteritis nodosa (PAN) is a primary form of vasculitis characterized by inflammation of primarily medium-sized arteries. ...Treatment of systemic primary PAN involves the use of systemic immunosuppressive therapy largely guided by the severity of disease. …
Polyarteritis nodosa (PAN) is a primary form of vasculitis characterized by inflammation of primarily medium-sized arteries. ...Treat …
Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management.
Trivioli G, Terrier B, Vaglio A. Trivioli G, et al. Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii84-iii94. doi: 10.1093/rheumatology/kez570. Rheumatology (Oxford). 2020. PMID: 32348510 Review.
Eosinophilic granulomatosis with polyangiitis is characterized by asthma, blood and tissue eosinophilia and small-vessel vasculitis. The clinical presentation is variable, but two main clinic-pathologic subsets can be distinguished: one hallmarked by positive ANCA and pred …
Eosinophilic granulomatosis with polyangiitis is characterized by asthma, blood and tissue eosinophilia and small-vessel vasculitis. …
Polyarteritis nodosa revisited: a review of historical approaches, subphenotypes and a research agenda.
Karadag O, Jayne DJ. Karadag O, et al. Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):135-142. Epub 2018 Feb 20. Clin Exp Rheumatol. 2018. PMID: 29465365 Free article. Review.
Polyarteritis nodosa (PAN) is a rare form of primary systemic vasculitis with heterogeneous presentations, treatments and disease course. ...Since differentiation of PAN from microscopic polyangiitis (MPA) and other ANCA vasculitides by the Chapel Hill conference st …
Polyarteritis nodosa (PAN) is a rare form of primary systemic vasculitis with heterogeneous presentations, treatments and dise …
11,786 results
You have reached the last available page of results. Please see the User Guide for more information.